PL1666463T3 - Kryształ związku indolowego zawierającego sulfonamid i sposób jego wytwarzania - Google Patents
Kryształ związku indolowego zawierającego sulfonamid i sposób jego wytwarzaniaInfo
- Publication number
- PL1666463T3 PL1666463T3 PL04772605T PL04772605T PL1666463T3 PL 1666463 T3 PL1666463 T3 PL 1666463T3 PL 04772605 T PL04772605 T PL 04772605T PL 04772605 T PL04772605 T PL 04772605T PL 1666463 T3 PL1666463 T3 PL 1666463T3
- Authority
- PL
- Poland
- Prior art keywords
- sulfonamide
- crystal
- producing
- same
- indole compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003318953 | 2003-09-10 | ||
| EP04772605A EP1666463B1 (en) | 2003-09-10 | 2004-09-01 | Crystal of sulfonamide-containing indole compound and process for producing the same |
| PCT/JP2004/012649 WO2005026118A1 (ja) | 2003-09-10 | 2004-09-01 | スルホンアミド含有インドール化合物の結晶およびその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1666463T3 true PL1666463T3 (pl) | 2011-04-29 |
Family
ID=34308544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04772605T PL1666463T3 (pl) | 2003-09-10 | 2004-09-01 | Kryształ związku indolowego zawierającego sulfonamid i sposób jego wytwarzania |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7754894B2 (https=) |
| EP (1) | EP1666463B1 (https=) |
| JP (1) | JP4435090B2 (https=) |
| KR (1) | KR20060120644A (https=) |
| CN (2) | CN101165049A (https=) |
| AT (1) | ATE486849T1 (https=) |
| AU (1) | AU2004272400B2 (https=) |
| BR (1) | BRPI0414314A (https=) |
| CA (1) | CA2536995C (https=) |
| CY (1) | CY1110975T1 (https=) |
| DE (1) | DE602004029907D1 (https=) |
| DK (1) | DK1666463T3 (https=) |
| ES (1) | ES2354286T3 (https=) |
| HR (1) | HRP20100631T1 (https=) |
| IL (2) | IL174059A0 (https=) |
| MX (1) | MXPA06002732A (https=) |
| NO (1) | NO335256B1 (https=) |
| NZ (1) | NZ546111A (https=) |
| PL (1) | PL1666463T3 (https=) |
| PT (1) | PT1666463E (https=) |
| RU (1) | RU2336269C2 (https=) |
| SI (1) | SI1666463T1 (https=) |
| TW (1) | TW200514770A (https=) |
| WO (1) | WO2005026118A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1666463T3 (da) * | 2003-09-10 | 2010-12-20 | Eisai R&D Man Co Ltd | Krystal af sulfonamidholdig indolforbindelse og fremgangsmåde til fremstilling deraf |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3868534B2 (ja) | 1996-05-24 | 2007-01-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド誘導体の製造法および中間体 |
| JP2000247949A (ja) | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
| WO2001056607A1 (en) * | 2000-02-03 | 2001-08-09 | Eisai Co., Ltd. | Integrin expression inhibitors |
| TWI283575B (en) * | 2000-10-31 | 2007-07-11 | Eisai Co Ltd | Medicinal compositions for concomitant use as anticancer agent |
| DK1666463T3 (da) * | 2003-09-10 | 2010-12-20 | Eisai R&D Man Co Ltd | Krystal af sulfonamidholdig indolforbindelse og fremgangsmåde til fremstilling deraf |
-
2004
- 2004-09-01 DK DK04772605.4T patent/DK1666463T3/da active
- 2004-09-01 ES ES04772605T patent/ES2354286T3/es not_active Expired - Lifetime
- 2004-09-01 RU RU2006111454/04A patent/RU2336269C2/ru not_active IP Right Cessation
- 2004-09-01 KR KR1020067004877A patent/KR20060120644A/ko not_active Ceased
- 2004-09-01 MX MXPA06002732A patent/MXPA06002732A/es active IP Right Grant
- 2004-09-01 CN CNA2007101667949A patent/CN101165049A/zh active Pending
- 2004-09-01 WO PCT/JP2004/012649 patent/WO2005026118A1/ja not_active Ceased
- 2004-09-01 PT PT04772605T patent/PT1666463E/pt unknown
- 2004-09-01 CA CA2536995A patent/CA2536995C/en not_active Expired - Fee Related
- 2004-09-01 BR BRPI0414314-0A patent/BRPI0414314A/pt not_active IP Right Cessation
- 2004-09-01 CN CNB2004800260696A patent/CN100406440C/zh not_active Expired - Fee Related
- 2004-09-01 NZ NZ546111A patent/NZ546111A/en not_active IP Right Cessation
- 2004-09-01 AU AU2004272400A patent/AU2004272400B2/en not_active Ceased
- 2004-09-01 DE DE602004029907T patent/DE602004029907D1/de not_active Expired - Lifetime
- 2004-09-01 US US10/571,279 patent/US7754894B2/en not_active Expired - Lifetime
- 2004-09-01 PL PL04772605T patent/PL1666463T3/pl unknown
- 2004-09-01 HR HR20100631T patent/HRP20100631T1/hr unknown
- 2004-09-01 JP JP2005513843A patent/JP4435090B2/ja not_active Expired - Fee Related
- 2004-09-01 EP EP04772605A patent/EP1666463B1/en not_active Expired - Lifetime
- 2004-09-01 SI SI200431578T patent/SI1666463T1/sl unknown
- 2004-09-01 AT AT04772605T patent/ATE486849T1/de active
- 2004-09-06 TW TW093126889A patent/TW200514770A/zh not_active IP Right Cessation
-
2006
- 2006-03-02 IL IL174059A patent/IL174059A0/en not_active IP Right Cessation
- 2006-04-05 NO NO20061545A patent/NO335256B1/no not_active IP Right Cessation
-
2009
- 2009-01-18 IL IL196569A patent/IL196569A0/en unknown
- 2009-06-09 US US12/480,959 patent/US20090247768A1/en not_active Abandoned
-
2010
- 2010-12-10 CY CY20101101136T patent/CY1110975T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY132094A (en) | Pyrrolo-triazine aniline compounds useful as kinase inhibitors | |
| NZ543722A (en) | Novel substituted 3-sulfur indoles | |
| IL166416A0 (en) | Biaryl diazabicloalkane amides as nicotinic acetylcholine agonists | |
| EE200200575A (et) | Meetod perindopriili ja selle farmatseutiliselt sobivate soolade sünteesimiseks | |
| CA2356300A1 (en) | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy | |
| GEP20105036B (en) | Perindopril | |
| IL172512A0 (en) | Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them | |
| CA2498415A1 (en) | Solid formulations comprising an indolinone compound | |
| SI1279665T1 (sl) | Postopek za pripravo perindoprila, njegovih analogov in njegovih soli, z uporabo 2,5-diokso-oksazolidin-intermediatnih spojin | |
| CY1107913T1 (el) | Πολυμορφικες και αλλες κρυσταλλικες μορφες cis-ftc | |
| MY138826A (en) | 2,7-substituted indoles | |
| ATE304014T1 (de) | Neue kristalline form eines pyrrolidylthiocarbapenem-derivates | |
| AU2003273219A1 (en) | Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange | |
| HUP0300231A3 (en) | Process for the preparation of high purity perindopril and intermediates useful in the synthesis, pharmaceutical compositions containing the compound and their use | |
| WO2005005461A3 (fr) | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables | |
| GEP20074257B (en) | Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in the synthesis of perindopril | |
| GEP20084547B (en) | Method for synthesis of perindopril and pharmaceutically acceptable salts thereof | |
| MY139159A (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
| SI1666463T1 (sl) | Kristal indolne spojine, ki vsebuje sulfonamid, in postopek za njegovo pripravo | |
| MY135359A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
| MY136288A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
| PL379629A1 (pl) | Nowy sposób syntezy perindoprylu oraz jego farmaceutycznie dopuszczalnych soli | |
| MY135169A (en) | NEW PROCESS FOR THE SYNTHESIS OF (2S, 3aS, 7aS)-PERHYDROINDOLE-2-CARBOXYLIC ACID AND ESTERS THEREOF, AND APPLICATION IN THE SYNTHESIS OF PERINDOPRIL | |
| MY136638A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
| MY136989A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof |